160 related articles for article (PubMed ID: 17002160)
1. [PPAR agonists do not come up to expectations. Hope about the preventive effect in type 2 diabetes has come to nought].
Olsson AG
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2454-5. PubMed ID: 17002160
[No Abstract] [Full Text] [Related]
2. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
Schatz H
Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
[No Abstract] [Full Text] [Related]
3. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
Szymborska-Kajanek A; Strojek K
Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
[No Abstract] [Full Text] [Related]
4. Fenofibrate and cardiovascular risk: a synopsis and commentary on (FIELD).
Bailey CJ
Diabet Med; 2006 Feb; 23(2):109-12. PubMed ID: 16433706
[No Abstract] [Full Text] [Related]
5. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
Båvenholm P; Attvall S; Nilsson PM
Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
[No Abstract] [Full Text] [Related]
6. Comment on: Boden et al. (2007) Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention: Diabetes 56:248-255.
Karalliedde J; Viberti GC
Diabetes; 2007 May; 56(5):e3; author reply e4. PubMed ID: 17470560
[No Abstract] [Full Text] [Related]
7. Dual PPAR alpha/gamma agonists: promises and pitfalls in type 2 diabetes.
Ahmed I; Furlong K; Flood J; Treat VP; Goldstein BJ
Am J Ther; 2007; 14(1):49-62. PubMed ID: 17303976
[TBL] [Abstract][Full Text] [Related]
8. [How does the PROactive Study change therapy of diabetes?].
Erdmann E
MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
[No Abstract] [Full Text] [Related]
9. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
10. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):34L-40L. PubMed ID: 19084088
[TBL] [Abstract][Full Text] [Related]
11. What to make of ACCORD. Surprising new results from the landmark diabetes study.
Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):1-2, 7. PubMed ID: 20848750
[No Abstract] [Full Text] [Related]
12. A lesson in moderation: applying pharmacodynamics to clarify the relationship between thiazolidinediones and adverse vascular outcomes in type 2 diabetes.
Lehmann DF; Lohray BB
J Clin Pharmacol; 2008 Aug; 48(8):999-1002. PubMed ID: 18650500
[No Abstract] [Full Text] [Related]
13. Therapy and clinical trials.
Usman M; Peter R
Curr Opin Lipidol; 2006 Oct; 17(5):612-4. PubMed ID: 16960511
[No Abstract] [Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
15. [Type 2 diabetes: is the treatment based on evidence?].
Boussageon R
Rev Med Suisse; 2010 Sep; 6(260):1624-5; author reply 1625. PubMed ID: 20853719
[No Abstract] [Full Text] [Related]
16. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
17. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
[No Abstract] [Full Text] [Related]
18. Should we dismiss fibrates for the treatment of diabetic dyslipidaemia?
Taskinen MR
Nutr Metab Cardiovasc Dis; 2006 Dec; 16(8):509-12. PubMed ID: 17071064
[No Abstract] [Full Text] [Related]
19. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
Einecke D
MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
[No Abstract] [Full Text] [Related]
20. [Prospective pioglitazone clinical trial in macrovascular events].
Asanuma H; Kitakaze M
Nihon Rinsho; 2012 May; 70 Suppl 3():301-8. PubMed ID: 22768537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
